跳至主要内容
临床试验/CTRI/2025/08/093911
CTRI/2025/08/093911尚未招募2 期

Comparitive study of Kasahar mahakashay and Panchmooli kwath in Vataj kasa w.s.r to Allergic bronchitis.

DrPratima Dilip Ghate1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2025年11月5日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
140
试验地点
1
主要终点
There may be significant effect of Kasahar Mahakashay and Panchmooli kwath in the management of Kasa

研究概览

简要总结

This is a comparitive randomized clinical study  to assess their efficacy in Vataj kasa with special reference to allergic bronchitis.Due to rapid industialization ,urbanization,increased pollutants with the high  level of susceptibility of infections make the natural resistance of the human body weaker,leading to different clinical conditions. One such respiratory illness is vataj kasa vyadhi .Cough is the second most common symptom  to the extent of 4.29% prevalence in the primary care practice in india. If it becomes more chronic ,can cause impairement of the quality of life.The description of vataj kasa vyadhi mentioned in ayurvedic classics can be corelated with Allergic bronchitis.The concept of asatmya that is unfavourable mentioned in charak samhita can be compared with this condition.Hence a need to find an effective medication for the treatment of vataj kasa vyadhi. In proposed research plan two kashayas that is Kasahar mahakashay and panchmooli kwath were selected from ayurvedic classics with the aim to evaluate and compare their efficacy and also to assess the efficacy in Absolute eosinophil count and immunoglobulin E.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
17.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patient from 17-60 years of age having signs and symptoms of vataj kasa and allergic bronchitis.

排除标准

  • Patient below 17 year and above 60 years of ageChronic lung diseases COPD TB Carcinoma pregnancy lactation.

结局指标

主要结局

There may be significant effect of Kasahar Mahakashay and Panchmooli kwath in the management of Kasa

时间窗: 30 days

次要结局

  • This clinical study will be effective in allergic conditions & also enhances immuno modulating actions(30 days)

研究者

发起方
DrPratima Dilip Ghate
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

DrPratima Dilip Ghate

Ananya Ayurved College and hosital Kolol

研究点 (1)

Loading locations...

相似试验